FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pulmonology, and may be used for treating aggravated pulmonary disease or pulmonary disturbance. For this purpose, during an episode of aggravation, a therapeutically effective amount of a pharmaceutical composition containing purified alpha-1-antitrypsin (AAT) is introduced into patient's lungs by inhalation wherein the pharmaceutical composition is a ready aqueous sterile solution.
EFFECT: invention provides treating periods of aggravated pulmonary diseases.
25 cl, 1 ex
Authors
Dates
2013-01-20—Published
2007-02-08—Filed